Pages that link to "Q46007433"
Jump to navigation
Jump to search
The following pages link to Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. (Q46007433):
Displaying 19 items.
- Mesenchymal stem cells avoid allogeneic rejection (Q21245658) (← links)
- Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro (Q24794867) (← links)
- Leukocyte homing, fate, and function are controlled by retinoic acid (Q26865933) (← links)
- Melanoma-associated expression of transforming growth factor-beta isoforms (Q35773976) (← links)
- Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy (Q36135815) (← links)
- Induction of Smad1 by MT1-MMP contributes to tumor growth (Q36157381) (← links)
- Enhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cells (Q36644133) (← links)
- TGF-beta1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival (Q36944063) (← links)
- Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer (Q37616967) (← links)
- TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein (Q40242882) (← links)
- Suppressin: an endogenous negative regulator of immune cell activation (Q40615978) (← links)
- Autocrine secretion of TGF-beta 1 and TGF-beta 2 by pre-adipocytes and adipocytes: a potent negative regulator of adipocyte differentiation and proliferation of mammary carcinoma cells (Q41031197) (← links)
- The role of transforming growth factor beta in glioma progression (Q41731369) (← links)
- Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas (Q41911470) (← links)
- Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma. (Q55037666) (← links)
- Circulating immunoglobulin-bound transforming growth factor beta at a late tumour-bearing stage impairs antigen-specific responses of CD4+ T cells (Q74217242) (← links)
- Enhancing the immunotherapeutic potential of mycobacteria by transfection with tumour necrosis factor-alpha (Q77419150) (← links)
- Evaluation of the interaction between TGF beta and nitric oxide in the mechanisms of progression of colon carcinoma (Q81232709) (← links)
- Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer (Q82948307) (← links)